5-Years of Thrombolytic Treatment Experience

Alpay Tuncar; Hayri Canbaz; Attila Beştemir

Makale detayları

5-Years of Thrombolytic Treatment Experience

Yazarlar:

Alpay Tuncar | Hayri Canbaz | Attila Beştemir

Yayıncı:

Dicle University

Ana Başlıklar:

Tıp Eğitimi

Dergi:

Dicle Tıp Dergisi , pp.297-303

Belge Tipi:

Makale

Yayın Tarihi:

9/2023

Belge Dili:

İngilizce

Document ID (Org No.):

2001298560

pISSN:

1300-2945

Anahtar kelimeler:

Özet:

 Objective: Thrombolytic therapy has a vital role in saving both life and vital functions in emergency room patients. Our aim in our study is to reveal the thrombolytic practice experience of a 3rd level hospital in a long period of 5 years. Methods: Adult patients who applied to the emergency department between 2017-2022 and were given thrombolytic therapy were selected. Demographic information, risk factors, laboratory and radiological parameters, diagnoses and thrombolytic use of the patients were examined. Results: 56 patients were included in the study. Survival in patients with comorbidity was lower than in patients without comorbidity p0.0036. Survival of patients with a history of cerebrovascular occlusion was lower than those without p0.01. There was no statistically significant difference in survival between patients who received coagulation therapy in their history and patients p0.05. Survival analysis was performed according to the diagnosis of the patients in the emergency department. There was no statistical significance in terms of survival among patients with different diagnosis types p0.098. No statistically significant difference was found in the survival analysis for different application sites of thrombolytic therapy as emergency room, clinical service and intensive care unit p0.85. It was observed that doctors started thrombolytic practice as of 2017, and the number of applications increased over the years. Conclusion: The favorable outcomes thrombolytic therapy have led an increase in the number of thrombolytic therapy conducted by ED clinicians while it was also seen that there was a reduction in morbidity and mortality over time.

 Objective: Thrombolytic therapy has a vital role in saving both life and vital functions in emergency room patients. Our aim in our study is to reveal the thrombolytic practice experience of a 3rd level hospital in a long period of 5 years. Methods: Adult patients who applied to the emergency department between 2017-2022 and were given thrombolytic therapy were selected. Demographic information, risk factors, laboratory and radiological parameters, diagnoses and thrombolytic use of the patients were examined. Results: 56 patients were included in the study. Survival in patients with comorbidity was lower than in patients without comorbidity p0.0036. Survival of patients with a history of cerebrovascular occlusion was lower than those without p0.01. There was no statistically significant difference in survival between patients who received coagulation therapy in their history and patients p0.05. Survival analysis was performed according to the diagnosis of the patients in the emergency department. There was no statistical significance in terms of survival among patients with different diagnosis types p0.098. No statistically significant difference was found in the survival analysis for different application sites of thrombolytic therapy as emergency room, clinical service and intensive care unit p0.85. It was observed that doctors started thrombolytic practice as of 2017, and the number of applications increased over the years. Conclusion: The favorable outcomes thrombolytic therapy have led an increase in the number of thrombolytic therapy conducted by ED clinicians while it was also seen that there was a reduction in morbidity and mortality over time.

 Objective: Thrombolytic therapy has a vital role in saving both life and vital functions in emergency room patients. Our aim in our study is to reveal the thrombolytic practice experience of a 3rd level hospital in a long period of 5 years. Methods: Adult patients who applied to the emergency department between 2017-2022 and were given thrombolytic therapy were selected. Demographic information, risk factors, laboratory and radiological parameters, diagnoses and thrombolytic use of the patients were examined. Results: 56 patients were included in the study. Survival in patients with comorbidity was lower than in patients without comorbidity p0.0036. Survival of patients with a history of cerebrovascular occlusion was lower than those without p0.01. There was no statistically significant difference in survival between patients who received coagulation therapy in their history and patients p0.05. Survival analysis was performed according to the diagnosis of the patients in the emergency department. There was no statistical significance in terms of survival among patients with different diagnosis types p0.098. No statistically significant difference was found in the survival analysis for different application sites of thrombolytic therapy as emergency room, clinical service and intensive care unit p0.85. It was observed that doctors started thrombolytic practice as of 2017, and the number of applications increased over the years. Conclusion: The favorable outcomes thrombolytic therapy have led an increase in the number of thrombolytic therapy conducted by ED clinicians while it was also seen that there was a reduction in morbidity and mortality over time.

 Objective: Thrombolytic therapy has a vital role in saving both life and vital functions in emergency room patients. Our aim in our study is to reveal the thrombolytic practice experience of a 3rd level hospital in a long period of 5 years. Methods: Adult patients who applied to the emergency department between 2017-2022 and were given thrombolytic therapy were selected. Demographic information, risk factors, laboratory and radiological parameters, diagnoses and thrombolytic use of the patients were examined. Results: 56 patients were included in the study. Survival in patients with comorbidity was lower than in patients without comorbidity p0.0036. Survival of patients with a history of cerebrovascular occlusion was lower than those without p0.01. There was no statistically significant difference in survival between patients who received coagulation therapy in their history and patients p0.05. Survival analysis was performed according to the diagnosis of the patients in the emergency department. There was no statistical significance in terms of survival among patients with different diagnosis types p0.098. No statistically significant difference was found in the survival analysis for different application sites of thrombolytic therapy as emergency room, clinical service and intensive care unit p0.85. It was observed that doctors started thrombolytic practice as of 2017, and the number of applications increased over the years. Conclusion: The favorable outcomes thrombolytic therapy have led an increase in the number of thrombolytic therapy conducted by ED clinicians while it was also seen that there was a reduction in morbidity and mortality over time.

Makale detayları

5-Years of Thrombolytic Treatment Experience

Yazarlar:

Alpay Tuncar | Hayri Canbaz | Attila Beştemir

Yayıncı:

Dicle University

Ana Başlıklar:

Tıp Eğitimi

Dergi:

Dicle Tıp Dergisi , pp.297-303

Belge Tipi:

Makale

Yayın Tarihi:

9/2023

Belge Dili:

İngilizce

Document ID (Org No.):

2001298560

pISSN:

1300-2945

Emergency department

thrombolytic treatment

comorbidity

mortality.

Sayı

Makale detayları

5-Years of Thrombolytic Treatment Experience

Yazarlar: Alpay Tuncar | Hayri Canbaz | Attila Beştemir

Yayıncı: Dicle University

Ana Başlıklar: Tıp Eğitimi

Dergi: Dicle Tıp Dergisi , pp.297-303

Belge Tipi: Makale

Yayın Tarihi: 9/2023

Belge Dili: İngilizce

Document ID (Org No.): 2001298560

pISSN: 1300-2945

Emergency department

thrombolytic treatment

comorbidity

mortality.

Sayı

Yazarlar:

Alpay Tuncar | Hayri Canbaz | Attila Beştemir

Yayıncı:

Dicle University

Ana Başlıklar:

Tıp Eğitimi

Dergi:

Dicle Tıp Dergisi , pp.297-303

Belge Tipi:

Makale

Yayın Tarihi:

9/2023

Belge Dili:

İngilizce

Document ID (Org No.):

2001298560

pISSN:

1300-2945